Infladrop

Bromfenac, the active ingredient in Infladrop, is a nonsteroidal anti‑inflammatory drug presented as an ophthalmic solution for ocular use. It is indicated for reducing inflammation and pain after eye surgery and for other ocular inflammatory conditions in adult patients.\n\nGNH India supplies Infladrop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infladrop, a bromfenac‑based ophthalmic NSAID, is employed to manage inflammation within the eye.\n\nPost‑operative cataract surgery inflammation: reduces ocular swelling, pain and redness following cataract extraction.\nOther ocular inflammatory conditions: helps control pain and inflammation in disorders such as uveitis or postoperative inflammation after other intraocular procedures.

Infladrop may cause a range of ocular reactions.\n\nCommon Side Effects:\n- Burning or stinging sensation upon instillation\n- Transient foreign‑body feeling\n- Blurred vision lasting a few minutes\n- Conjunctival hyperemia (redness)\n- Increased tearing\n- Mild eyelid irritation\n\nSerious or Rare Side Effects:\n- Corneal ulceration or epithelial defect\n- Significant rise in intra‑ocular pressure\n- Severe allergic reaction (e.g., angio‑edema)\n- Persistent eye pain or vision loss\n- Hypersensitivity leading to swelling of the eyelids\n- Endophthalmitis (rare infection).

Before using Infladrop, consider the following precautions.\n\nAssess for hypersensitivity: avoid in patients with known allergy to bromfenac or other NSAIDs.\nAvoid use in active ocular infection: inflammation may mask infection signs.\nMonitor intra‑ocular pressure: especially in glaucoma patients.\nUse with caution in patients on systemic anticoagulants: increased bleeding risk.\nStore at room temperature: keep in original container, protect from light and moisture.

Infladrop can interact with other ophthalmic and systemic agents.\n\nMajor Interactions (Avoid):\n- Concurrent ocular NSAIDs: additive toxicity may increase corneal complications.\n- Systemic NSAIDs: heightened risk of systemic adverse effects such as gastrointestinal irritation.\n- Corticosteroid eye drops: may mask signs of infection or inflammation.\n\nModerate Interactions (Monitor Closely):\n- Anticholinergic eye drops: possible pupil dilation and blurred vision.\n- Beta‑blocker eye drops: monitor intra‑ocular pressure for additive effects.